High-yield bonds have gotten hammered recently, which might have created an opportunity, especially for ETF investors. Still, weakness in junk could augur tough times ahead.
Fund manager Joel Greenblatt says that, historically, when small company stocks have been as expensive as they are now, they have delivered negative returns.
Tough times for pharma stock Theravance, a boost for a mini-congolerate, and better news ahead for CIT.
Barron’s technology reporter Tiernan Ray ran 9 smart watches through their paces. He shares his findings and his outlook for the category.
Brendan Conway previews the next issue of Barron’s magazine, including a look at growth opportunities in the wearables sector.
Going against the crowd now could yield investors better returns when the market turns , Jack Hough says in his Barron’s preview on the News Hub with Sara Murray.
Becca Followill, who covers energy pipelines for US Capital Advisors, offers advice, and a warning, about master limited partnerships.
The summer sales could apply to retail stocks which are cheap and undervalued, Jack Hough says in his Barron’s preview on the News Hub with Sara Murray.